154 related articles for article (PubMed ID: 38612910)
1. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
[TBL] [Abstract][Full Text] [Related]
2. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.
Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH
BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563
[TBL] [Abstract][Full Text] [Related]
3. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
[TBL] [Abstract][Full Text] [Related]
4. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
[TBL] [Abstract][Full Text] [Related]
5. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
[TBL] [Abstract][Full Text] [Related]
6. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer.
Yao J; Li G; Liu M; Yang S; Su H; Ye C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696
[TBL] [Abstract][Full Text] [Related]
7. Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.
Forsdahl S; Kiselev Y; Hogseth R; Mjelle JE; Mikkola I
PLoS One; 2014; 9(7):e102559. PubMed ID: 25029272
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
[TBL] [Abstract][Full Text] [Related]
10. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.
Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H
Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685
[TBL] [Abstract][Full Text] [Related]
11. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Eskander RN; Ali S; Dellinger T; Lankes HA; Randall LM; Ramirez NC; Monk BJ; Walker JL; Eisenhauer E; Hoang BH
Int J Gynecol Cancer; 2016 Jan; 26(1):125-32. PubMed ID: 26397159
[TBL] [Abstract][Full Text] [Related]
12. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.
Hara K; Kageji T; Mizobuchi Y; Kitazato KT; Okazaki T; Fujihara T; Nakajima K; Mure H; Kuwayama K; Hara T; Nagahiro S
Cancer Lett; 2015 Jan; 356(2 Pt B):496-505. PubMed ID: 25301448
[TBL] [Abstract][Full Text] [Related]
13. DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.
Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
J Oral Biosci; 2023 Dec; 65(4):334-346. PubMed ID: 37716425
[TBL] [Abstract][Full Text] [Related]
14. DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer.
Katase N; Kudo K; Ogawa K; Sakamoto Y; Nishimatsu SI; Yamauchi A; Fujita S
Oral Dis; 2023 Nov; 29(8):3193-3204. PubMed ID: 35708905
[TBL] [Abstract][Full Text] [Related]
15. Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
Dumke R; Dumke C; Eberle F; Nimsky C; Keber U; Engenhart-Cabillic R; Lautenschläger S
Strahlenther Onkol; 2022 Oct; 198(10):892-906. PubMed ID: 35612598
[TBL] [Abstract][Full Text] [Related]
16. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina.
Nakamura RE; Hunter DD; Yi H; Brunken WJ; Hackam AS
BMC Cell Biol; 2007 Dec; 8():52. PubMed ID: 18093317
[TBL] [Abstract][Full Text] [Related]
17. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
Guo Q; Qin W
J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
[TBL] [Abstract][Full Text] [Related]
18. Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.
Lu D; Bao D; Dong W; Liu N; Zhang X; Gao S; Ge W; Gao X; Zhang L
Lab Invest; 2016 Feb; 96(2):239-48. PubMed ID: 26641069
[TBL] [Abstract][Full Text] [Related]
19. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
[No Abstract] [Full Text] [Related]
20. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
